New Delhi: With coronavirus cases rising in the country, Serum Institute of India (SII) has written to the Union Health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster for adults.
SII Director Prakash Kumar Singh wrote the letter last week, PTI reported quoting officials.
COVID-19 Working Group, headed by Dr NK Arora, had last month recommended the inclusion of Covovax on CoWIN portal as a booster for adults who have received two doses of either Covishield or Covaxin.
India reported 3,641 fresh COVID-positive cases on Monday.
On January 16, Drugs Controller General of India (DCGI) approved the necessary market authorisation for Covovax as a heterologous booster.
Covovax has already been approved by World Health Organisation (WHO) and US Food and Drug Administration (USFDA).
Covovax is manufactured by SII through technology transfer from US-based vaccine maker Novavax.
Bhubaneswar: The Centre is committed to establishing Odisha's unique flavours in the global market, while… Read More
Bhubaneswar: An earthquake of magnitude 5.1 on the Richter scale was recorded on Tuesday morning… Read More
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most… Read More
Bhubaneswar: The Reserve Bank of India (RBI) here is observing the 10th edition of its… Read More
New Delhi/Bhubaneswar: Former RBI Governor Shaktikanta Das assumed charge as second Principal Secretary to the… Read More
Bhubaneswar: Over 100 student from Odisha will be taking part in a Winter Adventure Camp… Read More
This website uses cookies.
